The key mediators of LIF for the iCAF phenotype and TGFβ for the myCAF phenotype in pancreatic cancer are modulated by CAV1, which would explain the contradictory role of CAV1 in the TME, and the detailed mechanisms require further analysis. This evidence concerns the gene CAV1 and familial pancreatic carcinoma.